Keyphrases
Retinopathy of Prematurity
100%
Pseudophakia
54%
Aphakia
53%
Toddlers
43%
Infant Aphakia Treatment Study
39%
Visual Acuity
37%
Glaucoma
36%
Strabismus
34%
Postnatal Growth
34%
Acute Phase
33%
Congenital Nasolacrimal Duct Obstruction (CNLDO)
32%
Cataract Surgery
32%
Intraocular Lens
29%
Lensectomy
28%
Adverse Events
25%
Retinoblastoma
25%
Stereoacuity
25%
Refractive Error
23%
Unilateral Cataract
22%
Telemedicine
22%
Reoperation
22%
Study Registry
21%
Intermittent Exotropia
21%
Treatment Study
21%
Screening Criteria
21%
Nasolacrimal Duct Intubation
21%
Balloon Catheter Dilation
21%
Bilateral Cataract
19%
Glaucoma Suspect
19%
Birth Weight
18%
Confidence Interval
18%
Prism Diopter
16%
Surgical Outcomes
16%
Bilateral Cataract Surgery
16%
Epiphora
16%
Tears
16%
Albinism
16%
Visual Axis Opacification
15%
Lateral Rectus Recession
15%
Gestational Age
15%
Treatment Efficacy
14%
Premature Infant
14%
Cataract
14%
Visual Acuity Outcome
14%
Ocular Complications
13%
Nystagmus
13%
Postmenstrual Age
13%
Anterior Segment
12%
Visual Outcome
12%
Age at Surgery
12%
Medicine and Dentistry
Retinopathy of Prematurity
100%
Aphakia
78%
Pseudophakia
52%
Glaucoma
51%
Cataract
48%
Visual Acuity
47%
Cataract Surgery
43%
Pediatrics
35%
Postnatal Growth
34%
Telemedicine
33%
Nasolacrimal Duct Obstruction
32%
Intraocular Lens
31%
Strabismus
30%
Lensectomy
25%
Retinoblastoma
25%
Intubation
24%
Nasolacrimal Duct
24%
Exotropia
23%
Albinism
21%
Lateral Rectus Muscle
21%
Refractive Error
21%
Reoperation
20%
Adverse Event
19%
Birth Weight
18%
Vascularity
15%
Esotropia
15%
Epiphora
14%
Magnetic Resonance Imaging
14%
Gestational Age
14%
Prematurity
14%
Patient Referral
11%
Norrie Disease
10%
Eye Examination
10%
Agents Acting on the Eye
10%
Trabeculotomy
10%
Neuromuscular Junction
10%
Extraocular Muscle
10%
Analgesia
10%
Bevacizumab
10%
Botulinum Toxin A
10%
Rasch Analysis
10%
Sepsis
10%
Amblyopia
10%
Spontaneous Remission
10%
Red Reflex
10%
Health Care Cost
10%
Intraarterial Drug Administration
10%
Disease Exacerbation
10%
Clostridium Botulinum Type A
10%
Muscle Atrophy
10%